Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Basic Clin Physiol Pharmacol ; 33(5): 633-638, 2022 Sep 01.
Article in English | MEDLINE | ID: mdl-34913624

ABSTRACT

OBJECTIVES: Depression is a psychiatric disorder that affects about 10% of the world's population and is accompanied by anxiety. Depression and anxiety are often caused by various stresses. However, the etiology of depression and anxiety remains unknown. It has been reported that alpha2-antiplasmin (α2AP) not only inhibits plasmin but also has various functions such as cytokine production and cell growth. This study aimed to determine the roles of α2AP on the stress-induced depression and anxiety. METHODS: We investigated the mild repeated restraint stress-induced depressive and anxiety-like behavior in the α2AP+/+ and α2AP-/- mice using the social interaction test (SIT), sucrose preference test (SPT), and elevated plus maze (EPM). RESULTS: The stresses such as the mild repeated restraint stress suppressed α2AP expression in the hippocampus of mice, and the treatment of fluoxetine (selective serotonin reuptake inhibitor [SSRI]) recovered the stress-caused α2AP suppression. We also showed that α2AP deficiency promoted the mild restraint stress-stimulated depression-like behavior such as social withdrawal and apathy and apoptosis in mice. In contrast, α2AP deficiency attenuated the mild restraint stress induced the anxiety-like behavior in mice. CONCLUSIONS: α2AP affects the pathogenesis of depression and anxiety induced by stress.


Subject(s)
Anxiety/metabolism , Depression/metabolism , alpha-2-Antiplasmin/metabolism , Animals , Anxiety/pathology , Apoptosis , Behavior, Animal , Cytokines , Depression/pathology , Fibrinolysin , Fluoxetine/administration & dosage , Humans , Mice , Selective Serotonin Reuptake Inhibitors , alpha-2-Antiplasmin/deficiency
2.
Mol Microbiol ; 107(6): 688-703, 2018 03.
Article in English | MEDLINE | ID: mdl-29292548

ABSTRACT

The biosynthesis of iron-sulfur (Fe-S) clusters in Bacillus subtilis is mediated by the SUF-like system composed of the sufCDSUB gene products. This system is unique in that it is a chimeric machinery comprising homologues of E. coli SUF components (SufS, SufB, SufC and SufD) and an ISC component (IscU). B. subtilis SufS cysteine desulfurase transfers persulfide sulfur to SufU (the IscU homologue); however, it has remained controversial whether SufU serves as a scaffold for Fe-S cluster assembly, like IscU, or acts as a sulfur shuttle protein, like E. coli SufE. Here we report that reengineering of the isoprenoid biosynthetic pathway in B. subtilis can offset the indispensability of the sufCDSUB operon, allowing the resultant Δsuf mutants to grow without detectable Fe-S proteins. Heterologous bidirectional complementation studies using B. subtilis and E. coli mutants showed that B. subtilis SufSU is interchangeable with E. coli SufSE but not with IscSU. In addition, functional similarity in SufB, SufC and SufD was observed between B. subtilis and E. coli. Our findings thus indicate that B. subtilis SufU is the protein that transfers sulfur from SufS to SufB, and that the SufBCD complex is the site of Fe-S cluster assembly.


Subject(s)
Bacillus subtilis/genetics , Iron-Sulfur Proteins/biosynthesis , Iron-Sulfur Proteins/metabolism , Lyases/genetics , Operon , Amino Acid Sequence , Bacillus subtilis/metabolism , Bacterial Proteins/metabolism , Carbon-Sulfur Lyases/metabolism , Cysteine/metabolism , Escherichia coli/genetics , Escherichia coli Proteins/metabolism , Iron/metabolism , Lyases/metabolism , Models, Molecular , Protein Structural Elements , Protein Subunits/metabolism , Sulfur/metabolism
3.
J Am Chem Soc ; 139(51): 18464-18467, 2017 12 27.
Article in English | MEDLINE | ID: mdl-29235855

ABSTRACT

SufU is a zinc-containing protein involved in mobilization of sulfur from SufS for iron-sulfur cluster biogenesis of Bacillus subtilis. Structural basis for the sulfur transfer in SufS-SufU complex was revealed. A zinc-ligand exchange reaction upon SufS-SufU complexation provides a free thiol from Cys41 of SufU as a sulfur acceptor.


Subject(s)
Bacillus subtilis/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/metabolism , Iron-Sulfur Proteins/chemistry , Iron-Sulfur Proteins/metabolism , Sulfur/metabolism , Zinc/metabolism , Cysteine/chemistry , Cysteine/metabolism , Ligands
4.
Int J Mol Med ; 40(3): 854-858, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28677806

ABSTRACT

α2-antiplasmin (α2AP) is known to be a physiological inhibitor of plasmin. Previously, we showed that α2AP displays various functions, such as promotion of extracellular matrix production, cell growth, and cell differentiation that are not promoted by its function as a plasmin inhibitor. We herein investigated the role of α2AP in bone formation by examining calcein incorporation after its injection in α2AP-deficient mice. We found that α2AP deficiency enhanced the bone formation rate in mice. We also found that the osteocalcin expression and alkaline phosphatase activity were elevated in the femur and serum of the α2AP-deficient mice. Intriguingly, α2AP deficiency promoted osteoblast (OB) differentiation of primary calvarial OBs. In contrast, α2AP attenuated OB differentiation of mouse osteoblastic the MC3T3-E1 cells. Furthermore, α2AP attenuated Wnt-3a-induced ß-catenin expression and low­density lipoprotein receptor-related protein 6 activation in the MC3T3-E1 cells. These results suggest that α2AP negatively affects OB differentiation and function by inhibiting the Wnt/ß-catenin pathway. These findings provide a basis for clinical strategies to improve various bone disorders.


Subject(s)
Cell Differentiation , Osteoblasts/metabolism , Osteogenesis , Wnt Signaling Pathway , alpha-2-Antiplasmin/metabolism , Animals , Cell Line , Mice , Mice, Knockout , Wnt3A Protein/genetics , Wnt3A Protein/metabolism , alpha-2-Antiplasmin/genetics , beta Catenin/genetics , beta Catenin/metabolism
5.
Immun Inflamm Dis ; 5(3): 289-299, 2017 09.
Article in English | MEDLINE | ID: mdl-28493442

ABSTRACT

INTRODUCTION: Chronic inflammatory diseases such as rheumatoid arthritis and periodontitis frequently cause bone destruction. Inflammation-induced bone loss results from the increase of bone-resorbing osteoclasts. Recently, we demonstrated that urokinase type plasminogen activator (uPA) suppressed lipopolysaccaride (LPS)-inflammatory osteoclastogenesis through the adenosine monophosphate-activated protein kinase (AMPK) pathway, whereas its receptor (uPAR) promoted that through the Akt pathway. METHODS: We investigated the effects of uPA-derived peptide (Å6) in the LPS-induced inflammatory osteoclastogenesis and bone destruction. RESULTS: We found that Å6 attenuated inflammatory osteoclastogenesis and bone loss induced by LPS in mice. We also showed that Å6 attenuated the LPS-promoted inflammatory osteoclastogenesis by inactivation of NF-κB in RAW264.7 mouse monocyte/macrophage lineage cells. Furthermore, we showed that Å6 attenuated the Akt phosphorylation, and promoted the AMPK phosphorylation. CONCLUSION: Å6 is involved in the suppression of LPS-promoted inflammatory osteoclastgensis and bone destruction by regulating the AMPK and Akt pathways. These findings provide a basis for clinical strategies to improve the bone loss caused by inflammatory diseases.


Subject(s)
Bone Resorption/prevention & control , Lipopolysaccharides/toxicity , Osteoclasts/immunology , Peptides/pharmacology , Signal Transduction/drug effects , Urokinase-Type Plasminogen Activator/pharmacology , AMP-Activated Protein Kinases/immunology , Animals , Bone Resorption/chemically induced , Bone Resorption/immunology , Bone Resorption/pathology , Mice , Osteoclasts/pathology , Proto-Oncogene Proteins c-akt/immunology , Signal Transduction/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...